Completed PHASE2/PHASE3 INTERVENTIONAL NCT00143520

Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes

A Randomized, Double-blind, Double-dummy, Placebo-controlled 26-week Dose-response Study of Rivoglitazone HCl (CS-011) With Active Comparator (Pioglitazone HCl) in Subjects With Type 2 Diabetes

Sponsor: Daiichi Sankyo

Conditions Type 2 Diabetes

Interventions Pioglitazone Placebo Rivoglitazone

Updated 10 times since 2017 Last updated: May 6, 2021 Started: Dec 31, 2004 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Type 2 Diabetes and is currently completed. Daiichi Sankyo leads this study, which shows 10 recorded versions since 2004 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Mar 2024 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2021 — Mar 2024 [monthly]

Completed PHASE2_PHASE3

▶ Show 5 earlier versions

Jan 2021 — Jun 2021 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Sep 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Feb 2017 — Sep 2017 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daiichi Sankyo

Data source: Daiichi Sankyo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Birmingham, United States , Bozeman, United States , Bristol, United States , Butte, United States , Carrollton, United States , Charleston, United States , Charlotte, United States , Chicago, United States , Cincinnati, United States , Clearwater, United States and 64 more locations